EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Oral mucositis management with photobiomodulation, Bidens pilosa L. (Asteraceae) and Curcuma longa L. (Zingiberaceae), the FITOPROT herbal medicine, and its influence on inflammatory cytokine levels: a randomized clinical trial

Carlos Henrique Pereira, Allisson Filipe Lopes Martins, Marília Oliveira Morais, Sebastião Silvério de Sousa-Neto, Artur Christian Garcia da Silva, Diego Antonio Costa Arantes, Victor Hugo Lopes De Oliveira Moreira, Marize Campos Valadares, Nilceana Maya Aires Freitas, Cláudio Rodrigues Leles, Elismauro Francisco Mendonça

Supportive Care in Cancer · 2024

DOI: 10.1007/s00520-024-08842-3 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Supportive Care in Cancer, 2024. Verfasst von Carlos Henrique Pereira und 10 weiteren Autor:innen. Beteiligte Einrichtung: Araujo Jorge Cancer Hospital, R. 239, 206 - Setor Universitário, Goiânia, Goiás, CEP 74175-120, Brazil. Hauptthemen laut MEDLINE: Stomatitis, Curcuma, Cytokines, Bidens. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Financiadora de Estudos e Projetos.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: This randomized clinical trial aimed to compare the effects of a mucoadhesive formula, containing curcuminoids from Curcuma longa L. and glycerinated extract of Bidens pilosa L. (FITOPROT), associated with photobiomodulation (PBM), and of PBM exclusively, on the incidence of oral mucositis (OM)-induced by radiotherapy (RT) in the head and neck region, and the salivary expression of inflammatory cytokines, in patients with head neck cancer. METHODS: Patients were randomly assigned into two intervention groups-FITOPROT + PBM (n = 25) or PBM (n = 27). PBM protocol comprised a wavelength of 660 nm, 25 mW, 0.25 J/point, and daily irradiation from the first until the last day of RT. FITOPROT was gargled twice a day. All patients underwent a preventive oral care program throughout the study. OM degree, salivary concentration of nitrite, and inflammatory (IL-1, TNFα, IL-6, IL-8, and IL-12p70), and anti-inflammatory (IL-10) cytokines were assessed at baseline, and at the 7th, 14th, 21st, and 30th RT sessions. RESULTS: There were no differences in the OM degree between groups, but the RT dose significantly affected the OM. The RT significantly affected the salivary nitrite, TNFα, IL-1β, and IL-10 concentrations. CONCLUSION: FITOPROT associated with PBM showed limited effects on preventing the incidence of severe OM compared to PBM alone. However, FITOPROT + PBM may be associated with nitrite and cytokine balance, which may contribute to the occurrence of fewer cases of severe OM. TRIAL REGISTRATION: Brazilian Clinical Trials database (ReBEC; RBR-9vddmr), registered UTN code: U1111-1193-2066, registered in August 8th, 2017.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StomatitisCurcumaCytokinesBidensPlant ExtractsHead and Neck NeoplasmsHumansMiddle AgedMaleFemaleAgedLow-Level Light TherapyAdultSalivaPhytotherapy

Stichwörter der Autor:innen

CurcuminFITOPROTHead and neck cancerOral mucositisPhotobiomodulation

Substanzen

CytokinesPlant Extracts

Autor:innen und Institutionen

  • Araujo Jorge Cancer Hospital, R. 239, 206 - Setor Universitário, Goiânia, Goiás, CEP 74175-120, Brazil.
  • Department of Oral Diagnosis, School of Dentistry, Universidade Evangélica de Goiás, Dentistry School, Anápolis, Goiás, CEP 75083-515, Brazil.
  • Laboratory of Oral Pathology, School of Dentistry, Universidade Federal de Goiás, Avenida Universitária Esquina Com 1ª Avenida, S/N. Setor Universitário, Goiânia, Goiás, CEP 74605-220, Brazil.
  • Laboratory of Education and Research in In Vitro Toxicology, Tox In, Faculty of Pharmacy, Universidade Federal de Goiás, Rodovia R2, N. 3.061, Campus Samambaia, Goiânia, Goiás, CEP 74605.170, Brazil.
  • Department of Radiotherapy, Araujo Jorge Cancer Hospital, R. 239, 206-Setor Universitário, Goiânia, Goiás, CEP 74175-120, Brazil.
  • Department of Prevention and Oral Rehabilitation, School of Dentistry, Universidade Federal de Goiás, Avenida Universitária Esquina Com 1ª Avenida, S/N. Setor Universitário, Goiânia, Goiás, CEP 74605-220, Brazil.

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Financiadora de Estudos e Projetos

Zitieren

APA

Pereira, C. H., Martins, A. F. L., Morais, M. O., de Sousa-Neto, S. S., da Silva, A. C. G., Arantes, D. A. C., De Oliveira Moreira, V. H. L., Valadares, M. C., Freitas, N. M. A., Leles, C. R., & Mendonça, E. F. (2024). Oral mucositis management with photobiomodulation, Bidens pilosa L. (Asteraceae) and Curcuma longa L. (Zingiberaceae), the FITOPROT herbal medicine, and its influence on inflammatory cytokine levels: a randomized clinical trial. Supportive Care in Cancer. https://doi.org/10.1007/s00520-024-08842-3

Vancouver

Pereira CH, Martins AFL, Morais MO, de Sousa-Neto SS, da Silva ACG, Arantes DAC, et al. Oral mucositis management with photobiomodulation, Bidens pilosa L. (Asteraceae) and Curcuma longa L. (Zingiberaceae), the FITOPROT herbal medicine, and its influence on inflammatory cytokine levels: a randomized clinical trial. Supportive Care in Cancer. 2024. doi:10.1007/s00520-024-08842-3

BibTeX
@article{Pereira2024,
  author = {Pereira, Carlos Henrique and Martins, Allisson Filipe Lopes and Morais, Marília Oliveira and de Sousa-Neto, Sebastião Silvério and da Silva, Artur Christian Garcia and Arantes, Diego Antonio Costa and De Oliveira Moreira, Victor Hugo Lopes and Valadares, Marize Campos and Freitas, Nilceana Maya Aires and Leles, Cláudio Rodrigues and Mendonça, Elismauro Francisco},
  title = {Oral mucositis management with photobiomodulation, Bidens pilosa L. (Asteraceae) and Curcuma longa L. (Zingiberaceae), the FITOPROT herbal medicine, and its influence on inflammatory cytokine levels: a randomized clinical trial},
  journal = {Supportive Care in Cancer},
  year = {2024},
  doi = {10.1007/s00520-024-08842-3}
}
Kostenlos starten →